0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India General Anesthesia Drugs Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-1E15984
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global and India General Anesthesia Drugs Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India General Anesthesia Drugs Market Report & Forecast 2023-2029

Code: QYRE-Auto-1E15984
Report
November 2023
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India General Anesthesia Drugs Market Size

The global General Anesthesia Drugs revenue was US$ 3925.7 million in 2022 and is forecast to a readjusted size of US$ 4982.9 million by 2029 with a CAGR of 3.5% during the forecast period (2023-2029).

and India General Anesthesia Drugs Market

and India General Anesthesia Drugs Market

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
In India, the General Anesthesia Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.
This report focuses on global and India General Anesthesia Drugs market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for General Anesthesia Drugs will continue to grow rapidly in the future.
Global General Anesthesia Drugs Scope and Market Size
General Anesthesia Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global General Anesthesia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the General Anesthesia Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India General Anesthesia Drugs Market Report

Report Metric Details
Report Name and India General Anesthesia Drugs Market
Forecasted market size in 2029 US$ 4982.9 million
CAGR 3.5%
Forecasted years 2023 - 2029
Segment by Type
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Others
Segment by Application
  • Intravenous Anesthetics
  • Inhalational Anesthetics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India General Anesthesia Drugs Market size in 2029?

Ans: The and India General Anesthesia Drugs Market size in 2029 will be US$ 4982.9 million.

What is the market share of major companies in and India General Anesthesia Drugs Market?

Ans: The top three players hold a share about 37%.

What is the and India General Anesthesia Drugs Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India General Anesthesia Drugs Market report?

Ans: The main players in the and India General Anesthesia Drugs Market are Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang

What are the Application segmentation covered in the and India General Anesthesia Drugs Market report?

Ans: The Applications covered in the and India General Anesthesia Drugs Market report are Intravenous Anesthetics, Inhalational Anesthetics

What are the Type segmentation covered in the and India General Anesthesia Drugs Market report?

Ans: The Types covered in the and India General Anesthesia Drugs Market report are Propofol, Sevoflurane, Remifentanil, Etomidate, Isoflurane, Others

1 Study Coverage
1.1 General Anesthesia Drugs Product Introduction
1.2 Global General Anesthesia Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global General Anesthesia Drugs Sales in US$ Million for the Year 2018-2029
1.2.2 Global General Anesthesia Drugs Sales in Volume for the Year 2018-2029
1.3 India General Anesthesia Drugs Outlook 2018 VS 2022 VS 2029
1.3.1 India General Anesthesia Drugs Sales in US$ Million for the Year 2018-2029
1.3.2 India General Anesthesia Drugs Sales in Volume for the Year 2018-2029
1.4 General Anesthesia Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India General Anesthesia Drugs in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of General Anesthesia Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 General Anesthesia Drugs Market Dynamics
1.5.1 General Anesthesia Drugs Industry Trends
1.5.2 General Anesthesia Drugs Market Drivers
1.5.3 General Anesthesia Drugs Market Challenges
1.5.4 General Anesthesia Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 General Anesthesia Drugs by Type
2.1 General Anesthesia Drugs Market Segment by Type
2.1.1 Propofol
2.1.2 Sevoflurane
2.1.3 Remifentanil
2.1.4 Etomidate
2.1.5 Isoflurane
2.1.6 Others
2.2 Global General Anesthesia Drugs Market Size by Type
2.2.1 Global General Anesthesia Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global General Anesthesia Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global General Anesthesia Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India General Anesthesia Drugs Market Size by Type
2.3.1 India General Anesthesia Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India General Anesthesia Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India General Anesthesia Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 General Anesthesia Drugs by Application
3.1 General Anesthesia Drugs Market Segment by Application
3.1.1 Intravenous Anesthetics
3.1.2 Inhalational Anesthetics
3.2 Global General Anesthesia Drugs Market Size by Application
3.2.1 Global General Anesthesia Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global General Anesthesia Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global General Anesthesia Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India General Anesthesia Drugs Market Size by Application
3.3.1 India General Anesthesia Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India General Anesthesia Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India General Anesthesia Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global General Anesthesia Drugs Competitor Landscape by Company
4.1 Global General Anesthesia Drugs Market Size by Company
4.1.1 Global Key Manufacturers of General Anesthesia Drugs, Ranked by Revenue (2022)
4.1.2 Global General Anesthesia Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global General Anesthesia Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global General Anesthesia Drugs Price by Manufacturer (2018-2023)
4.2 Global General Anesthesia Drugs Concentration Ratio (CR)
4.2.1 General Anesthesia Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of General Anesthesia Drugs in 2022
4.2.3 Global General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of General Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of General Anesthesia Drugs, Product Offered and Application
4.5 Global Key Manufacturers of General Anesthesia Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India General Anesthesia Drugs Market Size by Company
4.7.1 Key Players of General Anesthesia Drugs in India, Ranked by Revenue (2022)
4.7.2 India General Anesthesia Drugs Revenue by Players (2018-2023)
4.7.3 India General Anesthesia Drugs Sales by Players (2018-2023)
5 Global General Anesthesia Drugs Market Size by Region
5.1 Global General Anesthesia Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global General Anesthesia Drugs Market Size in Volume by Region (2018-2029)
5.2.1 Global General Anesthesia Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global General Anesthesia Drugs Sales in Volume Forecast by Region (2024-2029)
5.3 Global General Anesthesia Drugs Market Size in Value by Region (2018-2029)
5.3.1 Global General Anesthesia Drugs Sales in Value by Region: 2018-2023
5.3.2 Global General Anesthesia Drugs Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas General Anesthesia Drugs Market Size YoY Growth 2018-2029
6.2 Americas General Anesthesia Drugs Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas General Anesthesia Drugs Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas General Anesthesia Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas General Anesthesia Drugs Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas General Anesthesia Drugs Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA General Anesthesia Drugs Market Size YoY Growth 2018-2029
7.2 EMEA General Anesthesia Drugs Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA General Anesthesia Drugs Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA General Anesthesia Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA General Anesthesia Drugs Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA General Anesthesia Drugs Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China General Anesthesia Drugs Market Size YoY Growth 2018-2029
8.2 China General Anesthesia Drugs Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China General Anesthesia Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC General Anesthesia Drugs Market Size YoY Growth 2018-2029
9.2 APAC General Anesthesia Drugs Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC General Anesthesia Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC General Anesthesia Drugs Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC General Anesthesia Drugs Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC General Anesthesia Drugs Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Aspen Pharma
10.1.1 Aspen Pharma Company Information
10.1.2 Aspen Pharma Description and Business Overview
10.1.3 Aspen Pharma General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Aspen Pharma General Anesthesia Drugs Products Offered
10.1.5 Aspen Pharma Recent Development
10.2 Fresenius-Kabi
10.2.1 Fresenius-Kabi Company Information
10.2.2 Fresenius-Kabi Description and Business Overview
10.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Fresenius-Kabi General Anesthesia Drugs Products Offered
10.2.5 Fresenius-Kabi Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Information
10.3.2 AbbVie Description and Business Overview
10.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AbbVie General Anesthesia Drugs Products Offered
10.3.5 AbbVie Recent Development
10.4 Baxter Healthcare
10.4.1 Baxter Healthcare Company Information
10.4.2 Baxter Healthcare Description and Business Overview
10.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Baxter Healthcare General Anesthesia Drugs Products Offered
10.4.5 Baxter Healthcare Recent Development
10.5 B.Braun
10.5.1 B.Braun Company Information
10.5.2 B.Braun Description and Business Overview
10.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B.Braun General Anesthesia Drugs Products Offered
10.5.5 B.Braun Recent Development
10.6 Maruishi
10.6.1 Maruishi Company Information
10.6.2 Maruishi Description and Business Overview
10.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Maruishi General Anesthesia Drugs Products Offered
10.6.5 Maruishi Recent Development
10.7 Piramal
10.7.1 Piramal Company Information
10.7.2 Piramal Description and Business Overview
10.7.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Piramal General Anesthesia Drugs Products Offered
10.7.5 Piramal Recent Development
10.8 Hikma Pharmaceuticals
10.8.1 Hikma Pharmaceuticals Company Information
10.8.2 Hikma Pharmaceuticals Description and Business Overview
10.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Products Offered
10.8.5 Hikma Pharmaceuticals Recent Development
10.9 Yichang Humanwell
10.9.1 Yichang Humanwell Company Information
10.9.2 Yichang Humanwell Description and Business Overview
10.9.3 Yichang Humanwell General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Yichang Humanwell General Anesthesia Drugs Products Offered
10.9.5 Yichang Humanwell Recent Development
10.10 Nhwa
10.10.1 Nhwa Company Information
10.10.2 Nhwa Description and Business Overview
10.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Nhwa General Anesthesia Drugs Products Offered
10.10.5 Nhwa Recent Development
10.11 Hengrui
10.11.1 Hengrui Company Information
10.11.2 Hengrui Description and Business Overview
10.11.3 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hengrui General Anesthesia Drugs Products Offered
10.11.5 Hengrui Recent Development
10.12 Xi'an Libang
10.12.1 Xi'an Libang Company Information
10.12.2 Xi'an Libang Description and Business Overview
10.12.3 Xi'an Libang General Anesthesia Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Xi'an Libang General Anesthesia Drugs Products Offered
10.12.5 Xi'an Libang Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 General Anesthesia Drugs Industry Chain Analysis
11.2 General Anesthesia Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 General Anesthesia Drugs Production Mode & Process
11.4 General Anesthesia Drugs Sales and Marketing
11.4.1 General Anesthesia Drugs Sales Channels
11.4.2 General Anesthesia Drugs Distributors
11.5 General Anesthesia Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. General Anesthesia Drugs CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. General Anesthesia Drugs Market Trends
    Table 3. General Anesthesia Drugs Market Drivers
    Table 4. General Anesthesia Drugs Market Challenges
    Table 5. General Anesthesia Drugs Market Restraints
    Table 6. Global General Anesthesia Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India General Anesthesia Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global General Anesthesia Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India General Anesthesia Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of General Anesthesia Drugs, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global General Anesthesia Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global General Anesthesia Drugs Revenue Share by Manufacturer, 2018-2023
    Table 13. Global General Anesthesia Drugs Sales by Manufacturer, (M Units), 2018-2023
    Table 14. Global General Anesthesia Drugs Sales Share by Manufacturer, 2018-2023
    Table 15. Global General Anesthesia Drugs Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 16. Global General Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthesia Drugs as of 2022)
    Table 18. Global Key Manufacturers of General Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of General Anesthesia Drugs, Product Offered and Application
    Table 20. Global Key Manufacturers of General Anesthesia Drugs, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of General Anesthesia Drugs in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India General Anesthesia Drugs Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India General Anesthesia Drugs Revenue Share by Players, (2018-2023)
    Table 25. India General Anesthesia Drugs Sales by Players, (M Units), (2018-2023)
    Table 26. India General Anesthesia Drugs Sales Share by Players, (2018-2023)
    Table 27. Global General Anesthesia Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global General Anesthesia Drugs Sales in Volume by Region (2018-2023) & (M Units)
    Table 29. Global General Anesthesia Drugs Sales in Volume Forecast by Region (2024-2029) & (M Units)
    Table 30. Global General Anesthesia Drugs Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global General Anesthesia Drugs Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas General Anesthesia Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas General Anesthesia Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas General Anesthesia Drugs Sales in Volume by Country (2018-2023) & (M Units)
    Table 36. Americas General Anesthesia Drugs Sales in Volume by Country (2024-2029) & (M Units)
    Table 37. EMEA General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA General Anesthesia Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA General Anesthesia Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA General Anesthesia Drugs Sales in Volume by Country (2018-2023) & (M Units)
    Table 41. EMEA General Anesthesia Drugs Sales in Volume by Country (2024-2029) & (M Units)
    Table 42. APAC General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC General Anesthesia Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC General Anesthesia Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC General Anesthesia Drugs Sales in Volume by Country (2018-2023) & (M Units)
    Table 46. APAC General Anesthesia Drugs Sales in Volume by Country (2024-2029) & (M Units)
    Table 47. Aspen Pharma Company Information
    Table 48. Aspen Pharma Description and Business Overview
    Table 49. Aspen Pharma General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 50. Aspen Pharma General Anesthesia Drugs Product
    Table 51. Aspen Pharma Recent Development
    Table 52. Fresenius-Kabi Company Information
    Table 53. Fresenius-Kabi Description and Business Overview
    Table 54. Fresenius-Kabi General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 55. Fresenius-Kabi General Anesthesia Drugs Product
    Table 56. Fresenius-Kabi Recent Development
    Table 57. AbbVie Company Information
    Table 58. AbbVie Description and Business Overview
    Table 59. AbbVie General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 60. AbbVie General Anesthesia Drugs Product
    Table 61. AbbVie Recent Development
    Table 62. Baxter Healthcare Company Information
    Table 63. Baxter Healthcare Description and Business Overview
    Table 64. Baxter Healthcare General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 65. Baxter Healthcare General Anesthesia Drugs Product
    Table 66. Baxter Healthcare Recent Development
    Table 67. B.Braun Company Information
    Table 68. B.Braun Description and Business Overview
    Table 69. B.Braun General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 70. B.Braun General Anesthesia Drugs Product
    Table 71. B.Braun Recent Development
    Table 72. Maruishi Company Information
    Table 73. Maruishi Description and Business Overview
    Table 74. Maruishi General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 75. Maruishi General Anesthesia Drugs Product
    Table 76. Maruishi Recent Development
    Table 77. Piramal Company Information
    Table 78. Piramal Description and Business Overview
    Table 79. Piramal General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 80. Piramal General Anesthesia Drugs Product
    Table 81. Piramal Recent Development
    Table 82. Hikma Pharmaceuticals Company Information
    Table 83. Hikma Pharmaceuticals Description and Business Overview
    Table 84. Hikma Pharmaceuticals General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 85. Hikma Pharmaceuticals General Anesthesia Drugs Product
    Table 86. Hikma Pharmaceuticals Recent Development
    Table 87. Yichang Humanwell Company Information
    Table 88. Yichang Humanwell Description and Business Overview
    Table 89. Yichang Humanwell General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 90. Yichang Humanwell General Anesthesia Drugs Product
    Table 91. Yichang Humanwell Recent Development
    Table 92. Nhwa Company Information
    Table 93. Nhwa Description and Business Overview
    Table 94. Nhwa General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 95. Nhwa General Anesthesia Drugs Product
    Table 96. Nhwa Recent Development
    Table 97. Hengrui Company Information
    Table 98. Hengrui Description and Business Overview
    Table 99. Hengrui General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 100. Hengrui General Anesthesia Drugs Product
    Table 101. Hengrui Recent Development
    Table 102. Xi'an Libang Company Information
    Table 103. Xi'an Libang Description and Business Overview
    Table 104. Xi'an Libang General Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 105. Xi'an Libang General Anesthesia Drugs Product
    Table 106. Xi'an Libang Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. General Anesthesia Drugs Customers List
    Table 110. General Anesthesia Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. General Anesthesia Drugs Product Picture
    Figure 2. Global General Anesthesia Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global General Anesthesia Drugs Market Size 2018-2029 (US$ Million)
    Figure 4. Global General Anesthesia Drugs Sales 2018-2029 (M Units)
    Figure 5. India General Anesthesia Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India General Anesthesia Drugs Market Size 2018-2029 (US$ Million)
    Figure 7. India General Anesthesia Drugs Sales 2018-2029 (M Units)
    Figure 8. India General Anesthesia Drugs Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India General Anesthesia Drugs Market Share in Global, in Volume (M Units) 2018-2029
    Figure 10. General Anesthesia Drugs Report Years Considered
    Figure 11. Product Picture of Propofol
    Figure 12. Product Picture of Sevoflurane
    Figure 13. Product Picture of Remifentanil
    Figure 14. Product Picture of Etomidate
    Figure 15. Product Picture of Isoflurane
    Figure 16. Product Picture of Others
    Figure 17. Global General Anesthesia Drugs Market Share by Type in 2022 & 2029
    Figure 18. Global General Anesthesia Drugs Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 19. Global General Anesthesia Drugs Sales Market Share in Value by Type (2018-2029)
    Figure 20. Global General Anesthesia Drugs Sales by Type (2018-2029) & (M Units)
    Figure 21. Global General Anesthesia Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 22. Global General Anesthesia Drugs Price by Type (2018-2029) & (US$/Unit)
    Figure 23. India General Anesthesia Drugs Market Share by Type in 2022 & 2029
    Figure 24. India General Anesthesia Drugs Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 25. India General Anesthesia Drugs Sales Market Share in Value by Type (2018-2029)
    Figure 26. India General Anesthesia Drugs Sales by Type (2018-2029) & (M Units)
    Figure 27. India General Anesthesia Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 28. India General Anesthesia Drugs Price by Type (2018-2029) & (US$/Unit)
    Figure 29. Product Picture of Intravenous Anesthetics
    Figure 30. Product Picture of Inhalational Anesthetics
    Figure 31. Global General Anesthesia Drugs Market Share by Application in 2022 & 2029
    Figure 32. Global General Anesthesia Drugs Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 33. Global General Anesthesia Drugs Sales Market Share in Value by Application (2018-2029)
    Figure 34. Global General Anesthesia Drugs Sales by Application (2018-2029) & (M Units)
    Figure 35. Global General Anesthesia Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 36. Global General Anesthesia Drugs Price by Application (2018-2029) & (US$/Unit)
    Figure 37. India General Anesthesia Drugs Market Share by Application in 2022 & 2029
    Figure 38. India General Anesthesia Drugs Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 39. India General Anesthesia Drugs Sales Market Share in Value by Application (2018-2029)
    Figure 40. India General Anesthesia Drugs Sales by Application (2018-2029) & (M Units)
    Figure 41. India General Anesthesia Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 42. India General Anesthesia Drugs Price by Application (2018-2029) & (US$/Unit)
    Figure 43. Americas General Anesthesia Drugs Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 44. Americas General Anesthesia Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 45. Americas General Anesthesia Drugs Sales by Type (2018-2029) & (M Units)
    Figure 46. Americas General Anesthesia Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 47. Americas General Anesthesia Drugs Sales by Application (2018-2029) & (M Units)
    Figure 48. Americas General Anesthesia Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 49. United States General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Canada General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Mexico General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Brazil General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 53. EMEA General Anesthesia Drugs Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 54. EMEA General Anesthesia Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 55. EMEA General Anesthesia Drugs Sales by Type (2018-2029) & (M Units)
    Figure 56. EMEA General Anesthesia Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 57. EMEA General Anesthesia Drugs Sales by Application (2018-2029) & (M Units)
    Figure 58. EMEA General Anesthesia Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 59. Europe General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Middle East General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. Africa General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 62. China General Anesthesia Drugs Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 63. China General Anesthesia Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 64. China General Anesthesia Drugs Sales by Type (2018-2029) & (M Units)
    Figure 65. China General Anesthesia Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 66. China General Anesthesia Drugs Sales by Application (2018-2029) & (M Units)
    Figure 67. China General Anesthesia Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 68. APAC General Anesthesia Drugs Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 69. APAC General Anesthesia Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 70. APAC General Anesthesia Drugs Sales by Type (2018-2029) & (M Units)
    Figure 71. APAC General Anesthesia Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 72. APAC General Anesthesia Drugs Sales by Application (2018-2029) & (M Units)
    Figure 73. APAC General Anesthesia Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 74. Japan General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. South Korea General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. China Taiwan General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. Southeast Asia General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. India General Anesthesia Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 79. General Anesthesia Drugs Value Chain
    Figure 80. General Anesthesia Drugs Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS